Cite
HARVARD Citation
Geipel, A. et al. (2015). Entecavir Allows an Unexpectedly High Residual Replication of HBV Mutants Resistant to Lamivudine. Antiviral therapy. 20 (8), pp. 779-787. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geipel, A. et al. (2015). Entecavir Allows an Unexpectedly High Residual Replication of HBV Mutants Resistant to Lamivudine. Antiviral therapy. 20 (8), pp. 779-787. [Online].